ADH

(redirected from Atypical Ductal Hyperplasia)
Also found in: Thesaurus, Medical, Acronyms, Encyclopedia.

ADH

abbr.
antidiuretic hormone

ADH

abbreviation for
(Biochemistry) antidiuretic hormone. See vasopressin

ADH

antidiuretic hormone. Compare vasopressin.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.ADH - hormone secreted by the posterior pituitary gland (trade name Pitressin) and also by nerve endings in the hypothalamusADH - hormone secreted by the posterior pituitary gland (trade name Pitressin) and also by nerve endings in the hypothalamus; affects blood pressure by stimulating capillary muscles and reduces urine flow by affecting reabsorption of water by kidney tubules
pressor, vasoconstrictive, vasoconstrictor - any agent that causes a narrowing of an opening of a blood vessel: cold or stress or nicotine or epinephrine or norepinephrine or angiotensin or vasopressin or certain drugs; maintains or increases blood pressure
endocrine, hormone, internal secretion - the secretion of an endocrine gland that is transmitted by the blood to the tissue on which it has a specific effect
References in periodicals archive ?
Long term clinical follow-up of atypical ductal hyperplasia and lobular carcinoma in situ in breast core needle biopsies.
Ductal hyperplasia without atypia, atypical ductal hyperplasia, intraductal hyperplasia with atypia, and ductal papillomatosis were the proliferative lesions.
Rates of atypical ductal hyperplasia declined with less use of postmenopausal hormone treatment: findings from the Breast Cancer Surveillance Consortium.
Previous studies have shown that women who are diagnosed with atypical ductal hyperplasia are at a three- to five-fold increased risk of developing breast cancer.
Only about 60% of the breast cancers that develop in women with either atypical lobular hyperplasia or atypical ductal hyperplasia occur in the ipsilateral breast.
Additional objectives included determining the incidence of significant pathologic findings (SPF), defined as occult carcinoma and atypical hyperplasia (including atypical ductal hyperplasia [ADH] and atypical lobular hyperplasia [ALH]), in RMP specimens.
ADH-5 can solve multiple clinical problems including 1) differentiating hyperplasia of the usual type from atypical ductal hyperplasia, 2) identifying microinvasion and invasive ductal carcinoma, and 3) distinguishing basal phenotypes on triple negatives.
Atypical ductal hyperplasia (ADH), lobular carcinoma in situ (LCIS) and atypical lobular hyperplasia (ALH) may also present with calcifications that may exhibit high density, clustered punctuate calcification and tending to lack the characteristic features of DCIS such as rod shapes, ductal distribution and branching.
There's a continuum from normal ductal epithelium to ductal hyperplasia to atypical ductal hyperplasia, which can progress to breast cancer, Dr.
Atypical Ductal Hyperplasia is not technically a tumor but can feel or appear to be a mass on imaging.
Biopsies that showed atypical ductal hyperplasia, atypical lobular hyperplasia, lobular carcinoma in situ, or flat epithelial atypia were grouped as atypical epithelial lesions.

Full browser ?